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Chronic itch, or pruritus, is associated with a wide range of skin abnormalities. The mechanisms responsible for 
chronic itch induction and persistence remain unclear. We developed a mouse model in which a constitutively 
active form of the serine/threonine kinase BRAF was expressed in neurons gated by the sodium channel Nav1.8 
(BRAFNav1.8 mice). We found that constitutive BRAF pathway activation in BRAFNav1.8 mice results in ectopic 
and enhanced expression of a cohort of itch-sensing genes, including gastrin-releasing peptide (GRP) and 
MAS-related GPCR member A3 (MRGPRA3), in nociceptors expressing transient receptor potential vanilloid 1 
(TRPV1). BRAFNav1.8 mice showed de novo neuronal responsiveness to pruritogens, enhanced pruriceptor excit-
ability, and heightened evoked and spontaneous scratching behavior. GRP receptor expression was increased 
in the spinal cord, indicating augmented coding capacity for itch subsequent to amplified pruriceptive inputs. 
Enhanced GRP expression and sustained ERK phosphorylation were observed in sensory neurons of mice with 
allergic contact dermatitis– or dry skin–elicited itch; however, spinal ERK activation was not required for main-
taining central sensitization of itch. Inhibition of either BRAF or GRP signaling attenuated itch sensation in 
chronic itch mouse models. These data uncover RAF/MEK/ERK signaling as a key regulator that confers a 
subset of nociceptors with pruriceptive properties to initiate and maintain long-lasting itch sensation.
Introduction
The ability of the brain to discriminate pain from itch in order 
to make binary decisions — eliciting either withdrawal or 
scratching behavior — is critically dependent on the functional 
connectivity of the somatosensory system. Itch information, 
along with pain, is conveyed by primary afferents of the dor-
sal root ganglion (DRG) to the spinal cord and of the trigem-
inal ganglion neurons to the trigeminal subnucleus caudalis 
of the brainstem, respectively, which in turn supplies input 
to the somatosensory cortex through spinothalamic tract or 
trigeminothalamic tract neurons (1–4). At the molecular level, 
emerging evidence suggests that activation of GPCRs in sen-
sory neurons is likely responsible for relaying distinct types of 
acute stimulus-evoked itch (5–7). In addition, several transient 
receptor potential (TRP) channels, including TRP vanilloid 1 
(TRPV1) and TRPA1, have been implicated in mediating hista-
minergic and nonhistaminergic itch, respectively (8–10). In the 
spinal cord, gastrin-releasing peptide (GRP) receptor (GRPR) 
and neurons expressing GRPR are key mediators dedicated to 
the coding of itch sensation (11–13). In contrast to acute itch, 
chronic itch may arise from an altered or diseased state of the 
skin or immune or nervous systems or from a dysregulation 
of metabolism. Chronic itch represents a significant clinical 
problem, largely due to its resistance to most commonly used 
antihistamine-based therapies (14, 15). To date, little is known 
about signaling mechanisms underlying chronic itch in the ner-
vous system. At the cellular level, mice lacking the transcription 
factor Bhlhb5 in a subset of spinal cord cells showed a heightened 
itch transmission, presumably resulting from a loss of inhibi-
tory interneurons expressing Bhlhb5 during development (16). 
In contrast, mice lacking spinal GRPR+ neurons lack the ability 
to sense chronic itch (13). In sensory neurons, the conditional 
deletion of vesicular glutamate transporter 2 (Vglut2) results in 
spontaneous itch sensation (17, 18), and TRPA1 is important for 
dry skin itch (19). Ablation of neurons expressing MAS-related 
GPCR member A3 (MRGPRA) attenuates dry skin and allergic 
itch, suggesting that MRGPRA3+ neurons are also important 
for the development of chronic itch (20). Although GRPR has 
emerged as an important receptor for mediating acute itch, the 
function of GRPR and its cognate ligand GRP in chronic itch 
has not been characterized.
BRAF is a serine/threonine kinase that activates ERK, a mem-
ber of the MAPKs superfamily, through the RAF/MEK/ERK 
cascade. Upon activation, pERK triggers the expression of a 
plethora of transcription factors in the nucleus to regulate a 
wide array of cellular functions (21, 22). Our previous studies 
of conditional BRAF loss-of-function mice have uncovered an 
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essential role for RAF signaling in the extension of peripheral 
sensory projections as well as in the initial development of some 
of the DRG’s molecular makeup and central projections (23). 
To further explore potential roles of BRAF signaling in sensory 
transduction, we generated BRAFNav1.8 mice in which the BRAF 
kinase is selectively activated in sensory neurons expressing the 
sodium channel Nav1.8 by genetically replacing the wild-type 
Braf gene with a kinase-activated one in these neurons (24, 25). 
BRAFNav1.8 mice exhibited spontaneous scratching behavior, 
prompting us to hypothesize that BRAF signaling plays a role in 
pruriceptive transmission.
Results
Peptidergic and nonpeptidergic fibers maintain their cellular identity 
but show aberrant central projections in BRAFNav1.8 mice. The mutant 
V600EBRAF protein was strongly expressed in DRG neurons of 
BRAFNav1.8 mice (Supplemental Figure 1; supplemental material 
available online with this article; doi:10.1172/JCI70528DS1), and, 
as expected, the levels of phosphorylated MEK1/2 and ERK1/2 
(pMEK1/2 and pERK1/2) were significantly elevated in DRG neu-
rons of BRAFNav1.8 mice relative to those of wild-type mice (Figure 1, 
A and B). Total BRAF and CRAF expression levels did not dif-
fer in DRG neurons between BRAFNav1.8 and wild-type mice 
Figure 1
Increased levels of pMEK1/2 and pERK1/2 in sensory neurons and aberrant innervations in the spinal cords of BRAFNav1.8 mice. (A) A represen-
tative Western blot and (B) quantified data show increased levels of pMEK1/2 and pERK1/2 but unchanged total MEK1/2 and ERK1/2 levels in 
DRGs of BRAFNav1.8 mice. n = 6 per genotype. All the lanes were run on the same gel but are noncontiguous. *P < 0.05, **P < 0.01, BRAFNav1.8 
mice vs. wild-type. (C–F) Increased pERK+ cells are indicated by double staining with pERK (red) and IB4 (green) or with pERK (brown) in 
Trpv1+ (blue) cells in BRAFNav1.8 mice compared to wild-type mice. n = 4 per genotype. ***P < 0.001. (G–L) Expression of molecular markers with 
IB4 (green) in DRGs of wild-type and BRAFNav1.8 mice. (M) Quantitative comparison of DRG neurons between 2 groups. n = 3 per genotype. 
(N–P) Expression of (N) CGRP and (O) IB4 in the spinal cords of wild-type and BRAFNav1.8 mice. Arrows and arrowheads indicate 
(C and E) pERK+ or pERK– cells, respectively, and (G–L) IB4+ or IB4– cells, respectively. Scale bar: 20 μm.
Downloaded on April 20, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/70528
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 11   November 2013 4771
(Supplemental Figure 1). In wild-type mice, pERK+ neurons were 
sparse in DRGs (3.2%), but they were widespread in DRG neu-
rons of BRAFNav1.8 mice (30.9%) (Figure 1, C and D). The number 
of pERK+ cells increased similarly in DRG neurons at cervical, 
thoracic, and lumbar segmental levels (Supplemental Figure 2). 
The density of primary afferent fibers innervating in cervical and 
lumbar back hairy skin regions also increased in BRAFNav1.8 mice 
(Supplemental Figure 3). Ectopic pERK was detected in neurons 
expressing lectin-binding IB4 (a nonpeptidergic marker) and 
TRPV1, both commonly used markers for subsets of nocicep-
tors (26). The proportion of TRPV1+ neurons expressing pERK 
increased from 5.0% to 35.1% (Figure 1, E and F). In contrast, 
the proportions of neurons expressing NeuN (neuronal-specific 
nuclear protein, a neuronal marker), NF200 (a large-diameter 
and myelinated neuronal marker), peripherin (a small-diameter 
neuronal marker), CGRP, IB4, TRPV1, and P2X3 (a pain-sensing 
ATP-gated ion channel also expressed in IB4+ cells) were compara-
ble between the 2 groups (Figure 1, G–M). Thus, the fates of pep-
tidergic, nonpeptidergic, and large-diameter neurons were main-
tained in BRAFNav1.8 mice.
Peptidergic and nonpeptidergic fibers innervate laminae I and 
II outer layer (IIo) and lamina II inner layer (IIi) in the spinal cord, 
respectively (Figure 1, N–P). In BRAFNav1.8 mice, CGRP+ fibers 
expanded to lamina IIi and were colocalized with IB4, whereas 
the nonpeptidergic IB4+ fibers invaded laminae I and IIo domains 
(Figure 1, N–P). These findings reveal that an appropriate level of 
BRAF signaling is important in directing the segregation of pep-
tidergic and nonpeptidergic primary afferents to their respective 
target zones of the spinal cord.
Spontaneous and enhanced evoked scratching behavior of BRAFNav1.8 
mice. At around 6 weeks of age, about 50% of BRAFNav1.8 mice 
showed spontaneous scratching behavior, followed by skin lesions 
(Figure 2, A and B, and Supplemental Video 1). By 2 months of age, 
the majority of BRAFNav1.8 mice had visible skin lesions, most nota-
bly around the craniofacial areas (Figure 2B) and the neck region. 
Prior to the onset of spontaneous scratching, BRAFNav1.8 mice 
demonstrated a markedly enhanced scratching response to nape 
intradermal (i.d.) injection of a number of pruritogens, including 
chloroquine (CQ), a nonhistaminergic pruritogen mediated in part 
through MRGPRA3 (27), histamine, compound 48/80, and endo-
thelin-1 (Figure 2C). Scratching behavior elicited by intrathecal 
(i.t.) injection of GRP was also significantly enhanced (Figure 2C), 
suggesting augmented GRPR signaling. Therefore, both histamin-
ergic and nonhistaminergic itch were significantly enhanced, indi-
cating increased pruriceptive transmission from the periphery to 
the spinal cords of BRAFNav1.8 mice. To assess whether BRAF acti-
vation alters nociceptive processing, we carried out a series of pain 
behavioral tests prior to the onset of the spontaneous scratching. 
The responses of BRAFNav1.8 mice to either noxious or nonnoxious 
mechanical stimuli were normal (Supplemental Figure 4, A and B) 
as was acute thermal sensitivity (Supplemental Figure 4, C and D). 
In addition, BRAFNav1.8 mice exhibited normal licking and flinch-
ing responses to intraplantar injection of noxious chemicals such 
as formalin and mustard oil (Supplemental Figure 4, E and F). 
Thermal and mechanical hypersensitivity induced by intraplantar 
injection of capsaicin and complete Freund’s adjuvant was also 
normal (Supplemental Figure 5, A–D). Moreover, BRAFNav1.8 mice 
exhibited normal motor function prior to the onset of excessive 
scratching behavior (Supplemental Figure 5E).
Massive ectopic expression of GRP/GRPR signaling in BRAFNav1.8 mice. 
The enhanced itch behavior prompted us to assess the expression 
of GRP in DRG neurons of BRAFNav1.8 mice. The number of GRP+ 
cells nearly doubled in BRAFNav1.8 mice (13.5%) compared with 
that in wild-type mice (7.2%) (Figure 3, A–C). Consistent with the 
observation of little variability in pERK+ staining in DRGs or skin 
regions at different levels (Supplemental Figures 2 and 3), the 
percentage of GRP+ cells detected was similar at different spinal 
segmental levels (Supplemental Figure 6). The proportion of cells 
expressing Mrgpra3, as detected by in situ hybridization (ISH), 
increased strikingly from 5.2% to 19.0% (Figure 3, D–F). The per-
centage of cells expressing histamine 1 receptor (H1R), a key recep-
tor implicated in mediating histaminergic itch (28), increased 
from 12.7% to 20.0% (Figure 3, G–I). The ectopic expression of 
GRP, Mrgpra3, and H1R was found predominantly in TRPV1+ cells 
Figure 2
BRAFNav1.8 mice showed excessive spontaneous scratching and 
significantly enhanced pruritogen-evoked scratching. (A) BRAFNav1.8 
mice developed age-dependent spontaneous scratching behavior 
from 6 to 14 weeks. n = 6 to 8 per each time point. (B) BRAFNav1.8 mice 
developed skin lesions (arrows). (C) Prior to development of spon-
taneous scratching (at 4~6 weeks of age), BRAFNav1.8 mice showed 
significantly enhanced scratching responses to pruritogens injected 
into the nape (CQ; histamine [His]; compound 48/80 [48/80]; endo-
thelin-1 [ET-1]) or to GRP injected i.t. Saline was the vehicle control. 
*P < 0.05, ***P < 0.001, BRAFNav1.8 compared to WT littermates in the 
same test, BRAFNav1.8 vs. wild-type. n = 5–9.
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but also in TRPV1– cells (Figure 3, J–R); this was verified by their 
double staining with Trpv1 ISH (Figure 3, J–L and P–R) or TRPV1 
antibody staining (Figure 3, M–O).
We next examined coexpression of Mrgpra3 with other markers 
in DRG neurons. The proportion of pERK/Mrgpra3-coexpressing 
cells was not significantly increased in BRAFNav1.8 mice (Supple-
mental Figure 7, A, B, and J). In wild-type mice, Mrgpra3 was mainly 
expressed in P2X3+/peripherin+/NF200–/CGRP– cells (Supple-
mental Figure 7J). In BRAFNav1.8 DRG, despite the overall marked 
increase of Mrgpra3+ cells, the expression pattern of Mrgpra3 in 
P2X3+/peripherin+/NF200–/CGRP– cells was unchanged. However, 
the proportion of Mrgpra3+ cells coexpressing CGRP+, H1R+, and 
GRP+ significantly increased (Supplemental Figure 7J). Moreover, 
the numbers of cells coexpressing Mrgpra3 with pERK, NF200, 
peripherin, P2X3, GRP, CGRP, and H1R all markedly increased 
in BRAFNav1.8 mice (Supplemental Figure 7K), indicating that 
Mrgpra3 was ectopically expressed in several major types of DRG 
neurons, including both TRPV1+ and TRPV1– cells (Figure 3N), 
and most prominently in GRP+ cells (Supplemental Figure 7K).
To examine GRPR expression, we took advantage of GRPR-EGFP 
mice that allow the detection of GRPR+ neurons by anti-GFP stain-
ing. As expected, GFP expression was primarily restricted to lam-
ina I of the spinal cords of GRPR-EGFP mice (Figure 3S), but its 
expression expanded entirely into lamina II of the spinal cords in 
GRPR-EGFP/BRAFNav1.8 mice (Figure 3T). This expression was val-
idated by similar Grpr mRNA expansion detected by ISH (Figure 3, 
V and W). Consistently, GRP+ fibers were much more abundant 
and expanded into entire lamina II in BRAFNav1.8 mice (Figure 3, 
Y–AA), matching the marked increase of GRP in DRG neurons 
(Figure 3, A–C). Notably, we did not observe an upregulation of 
GRP immunostaining intrinsic to dorsal horn interneurons of 
BRAFNav1.8 mice relative to the control (Figure 3, Y–AA).
Figure 3
Ectopic expression of itch mediators in BRAFNav1.8 mice. (A–I) BRAFNav1.8 mice showed ectopic expression of (A–C) GRP, (D–F) Mrgpra3, and 
(G–I) H1R in DRGs. (J–R) BRAFNav1.8 mice showed increased expression of (M–O) Mrgpra3 (blue) but not (J–L) GRP (brown) and (P–R) H1R 
(brown) in Trpv1+ cells (blue in J–L and P–R; brown in M–O). (S–X) Enhanced expression of GRPR as shown by (S–U) GFP staining and (V–X) 
Grpr mRNA in the dorsal horns of BRAFNav1.8 mice. (Y–AA) Enhanced GRP in primary afferents of BRAFNav1.8 mice. All mice were 8~12 weeks of 
age, except in V–AA, where 2-week-old mice were used. Scale bar: 20 μm. (J–Q) Arrows and arrowheads indicate TRPV1+ and TRPV1– neurons, 
respectively. *P < 0.05, **P < 0.01, ***P < 0.001, BRAFNav1.8 mice vs. wild-type. n = 4.
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Increased percentage of DRG neurons responding to CQ and histamine. 
We next analyzed the response of dissociated DRG neurons to 
CQ and histamine using calcium imaging. The percentage of cells 
responsive to CQ significantly increased in BRAFNav1.8 neurons 
(8.5% wild-type vs. 19.4% BRAFNav1.8), whereas that of histamine- 
responsive cells increased without statistical significance (10.6% 
wild-type vs. 13.1% BRAFNav1.8) (Figure 4, A–C). Few wild-type cells 
responded to both CQ and histamine, whereas there were signifi-
cantly more cells responsive to both in BRAFNav1.8 neurons (1.6% 
wild-type vs. 6.1% BRAFNav1.8) (Figure 4, A–C, E, and F). Of capsaicin- 
responsive cells, the percentage of cells responsive to CQ (7.9% 
wild-type vs. 25.1% BRAFNav1.8) or to both CQ and histamine (3.8% 
wild-type vs. 15.2% BRAFNav1.8) increased significantly (Figure 4, 
D–F). Taken together, these data provide physiological evidence 
supporting de novo responsiveness of BRAFNav1.8 DRG neurons to 
pruritogens but not to capsaicin.
Increased excitability of DRG neurons in response to histamine and CQ. 
We next measured basic electrophysiological parameters of dis-
sociated DRG neurons using current clamp recording. Among 
cells ranging in size from 17.5 to 32.5 μm, 3 firing patterns were 
observed: single spike (SS), delayed, and tonic firing (Figure 5, A–C, 
and Supplemental Table 1). Overall, SS cells showed a larger diam-
eter, more hyperpolarized resting membrane potential, decreased 
input resistance, and higher rheobase values than delayed and 
tonic firing cells (Supplemental Table 1). Interestingly, the per-
centage of SS cells was much smaller in BRAFNav1.8 mice compared 
with that in wild-type mice (36.3% wild-type vs. 16.3% BRAFNav1.8), 
whereas the percentage of tonic firing cells almost doubled in 
BRAFNav1.8 mice (25.0% wild-type vs. 47.5% BRAFNav1.8) (Supple-
mental Table 1). The number of delayed firing cells remained the 
same (Supplemental Table 1). For either wild-type or BRAFNav1.8 
mice, the cells responsive to pruritogens were typically tonic firing 
cells, which were readily excitable (Figure 5, D, E, G, and H). Only 
on rare occasion did SS cells respond to pruritogens. The tonic fir-
ing population of cells in BRAFNav1.8 mice exhibited a small increase 
in soma diameter, whereas SS neurons showed a smaller rheobase 
value relative to that of the control (Supplemental Table 1). 
The percentage of small-diameter cells responsive to histamine 
and CQ increased substantially in BRAFNav1.8 mice (Figure 5, 
F and I). Despite this expansion, the response magnitudes, in terms 
of firing frequency in response to histamine or CQ, were largely 
the same (Figure 5, D, E, G, and H). Thus, there was a dramatic 
expansion of tonic firing cells at the expense of SS cells in tandem 
with increased expression of itch mediators. These changes might 
underlie the enhanced and spontaneous itch in BRAFNav1.8 mice.
Attenuated itch sensation of BRAFNav1.8 mice by a blockade of histamin-
ergic and GRP/GRPR signaling. To distinguish whether incessant 
scratching behavior was a result of aberrant projection of primary 
afferents or ectopic expression of itch mediators, we generated 
Grp–/– mice (Figure 6, A–C). Consistent with our previous obser-
vations (27), neither DRG neurons nor the spinal cords showed 
GRP staining in Grp–/– mice (Figure 6, D–G). A recent study 
claimed that GRP immunostaining is largely attributable to neu-
rons intrinsic to the dorsal spinal cord (29). To clarify this, we 
repeated the dorsal rhizotomy experiment (12). As expected, on the 
ipsilateral side almost all CGRP+ fiber staining in the dorsal horn 
Figure 4
Enhanced and de novo responses to CQ and histamine but 
not to capsaicin in DRG cells from BRAFNav1.8 mice. (A and B) 
Three representative traces of DRG cells from (A) wild-
type or (B) BRAFNav1.8 mice responsive to CQ (100 μM), 
histamine (50 μM), and capsaicin (Cap; 1 μM). (B) Note that 
one CQ-responsive cell tested also responded to histamine 
and capsaicin. (C) The percentage of CQ-responsive DRG 
cells, but not histamine- and capsaicin-responsive cells, was 
significantly increased in BRAFNav1.8 mice. More DRG cells 
responded to both CQ and histamine in BRAFNav1.8 mice 
than in wild-type mice. (D) Of all capsaicin-sensitive cells in 
BRAFNav1.8 mice, there was a significant increase of cells that 
responded to CQ or to both CQ and histamine, whereas no 
difference was detected in the percentage of cells responsive 
to both capsaicin and histamine. (E and F) Venn diagrams 
showing the relative proportions of DRG cells of (E) wild-type 
mice and (F) BRAFNav1.8 mice responsive to CQ, histamine, 
and capsaicin. *P < 0.05, **P < 0.01, BRAFNav1.8 vs. wild-type. 
n = 4 (a total of 1,161 cells were tested).
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was lost, confirming the success of dorsal rhizotomy (Figure 6, 
H–J and P). Similarly, GRP+ immunostaining was nearly abolished 
on the ipsilateral side of the surgery but remained intact on the 
contralateral side (Figure 6, K–P), confirming that the presence of 
GRP+ immunostaining in the superficial dorsal horn was primary 
afferents dependent. These results directly challenge a previous 
study showing strong GRP staining in the spinal cord after the 
dorsal root rhizotomy (29). Importantly, spontaneous scratching 
of BRAFNav1.8 mice was markedly diminished in either Grp–/– or 
Grpr KO mice and nearly abolished when GRPR+ neurons were 
ablated with bombesin-saporin (Figure 7A and ref. 13). Scratch-
ing induced by i.t. GRP was also dramatically reduced after i.p. 
injection of 77427, a small-molecule GRP blocker (ref. 30 and 
Figure 7B). Neither Grp–/– nor Grpr KO mice showed an inhibitory 
effect of 77427 on CQ-elicited scratching observed in wild-type 
mice (Figure 7B), demonstrating the specificity of 77427 as a GRP 
blocker and supporting the role of GRP as an itch neurotransmit-
ter in acute and chronic itch. Consistently, i.p. injection of 77427 
significantly reduced spontaneous scratching in BRAFNav1.8 mice 
(Figure 7C) as did chlorpheniramine, a histamine antagonist (28), 
and U0126, a MEK inhibitor (31) (Figure 7C). U0126 failed to 
attenuate scratching behavior elicited by CQ and histamine 
(Figure 7D). Hence, these results demonstrate that ectopic ERK 
activation and expression of GRP and H1R are responsible for the 
spontaneous scratching of BRAFNav1.8 mice.
Mice with chronic itch induced by allergic contact dermatitis and dry 
skin recapitulate ectopic ERK activation and expression of itch mediators 
in BRAFNav1.8 mice. To assess the relevance of BRAF signaling to the 
development of chronic itch, we used a mouse model of allergic con-
tact dermatitis (ACD), a prevalent skin disease triggered by direct 
skin contact with haptens or allergens, induced by topical appli-
cation of a chemical hapten, 2, 4-dinitrofluorobenzene (DNFB) 
(32). A hallmark of ACD is intractable chronic itch that is resis-
tant to antihistamines (33, 34). DNFB induces a T cell–mediated 
hypersensitivity reaction in human skin (35, 36) and similarly 
initiates sensitization and elicitation phases in mice that manifest 
Figure 5
Electrophysiological characterization of DRG cells from BRAFNav1.8 mice and wild-type mice. (A–C) The BRAFNav1.8 DRG cells exhibited altered 
distribution of firing properties. In both BRAFNav1.8 mutant and wild-type cells, 3 firing patterns were routinely observed as (A) SS, (B) delayed, 
and (C) tonic. (D, E, G, and H) Representative action potential firing patterns of wild-type and BRAFNav1.8 cells in response to (D and E) CQ and 
(G and H) histamine. The cells responding to pruritogens typically exhibited tonic firing properties with low rheobase values. Response magnitude 
was generally similar between wild-type and BRAFNav1.8 mice. (F and I) Venn diagrams of total DRG cells showing that the percentage changes 
of DRG cells responsive to (F) CQ and (I) histamine substantially increased in BRAFNav1.8 mice relative to wild-type mice. (F) CQ (1 mM) induced 
action potential firing in 3 out of 44 (6.8%) wild-type DRG cells and in 8 out of 61 (13.1%) mutant DRG cells. (I) Histamine (100 μM) induced action 
potential firing in 7 out of 44 (15.9%) wild-type DRG cells and in 14 out of 61 (23.0%) mutant DRG cells. 
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as spontaneous scratching behavior (ref. 37 and see below). DNFB 
treatment resulted in thickening of epidermis, increased lymph 
node and spleen size, increased number of neutrophils, infiltration 
of inflammatory mast cells, and elevated serum IgE levels (Figure 8, 
A–E). The number of white blood cells also increased, but the dif-
ference was not statistically significant (Figure 8C). Thymic stromal 
lymphopoietin (TSLP), a marker for skin inflammation and der-
matitis (38), also increased significantly (Figure 8F). Importantly, 
DNFB-induced spontaneous scratching was significantly dimin-
ished by i.t. U0126 (Figure 9C). In mice treated with DNFB, ectopic 
ERK activation and expression of GRP and Mrgpra3 were detected 
in DRG neurons (Figure 9, D–L), and increased GRPR expression 
was detected in the spinal cord (Figure 9, M–O).
Finally, we analyzed whether BRAF signaling may have a role in 
itch induced by skin dryness (xerosis). Dry skin is caused by dis-
rupting cutaneous barrier function and is associated with rough, 
scaly, and flaky skin often accompanied by chronic pruritus (39). 
Topical application of an acetone/ether mixture followed by water 
leads to spontaneous scratching (Figure 9B), resulting from skin 
stratum corneum dehydration and epidermal water loss, and dry 
skin itch is mediated by histamine-independent mechanisms 
(40, 41). Similarly, dry skin itch was attenuated by U0126 (Figure 9C). 
Ectopic ERK activation and expression of GRP, Mrgpra3, and 
GRPR were observed in DRG neurons of mice with dry skin itch 
(Supplemental Figure 8). To assess whether spinal ERK activation 
is required to maintain spontaneous itch, we examined ERK acti-
vation in the dorsal horns of mice 1 day after the last DNFB or 
dry skin treatment. For a direct comparison of pERK activation to 
central hypersensitivity, pERK staining after intraplantar capsaicin 
injection (a model of inflammatory pain) was used as the control 
(ref. 42 and Supplemental Figure 9). We did not detect pERK+ 
cells in the spinal cord, despite ongoing spontaneous itch in both 
chronic itch models (Supplemental Figure 9), indicating that pERK 
upregulation in DRG instead of the spinal cord is necessary and 
sufficient for maintaining both peripheral and central sensitiza-
tion. Interestingly, CGRP+ and IB4+ fibers projected normally in the 
dorsal horns of mice with ACD and dry skin itch (Supplemental 
Figure 10), unlike the expansion of peptidergic and nonpeptidergic 
Figure 6
Generation of Grp–/– mice and 
confirmation of GRP expres-
sion in primary sensory neurons.  
(A) Targeting strategy for genera-
tion of Grp–/– mice. (B and C) Germ 
line transmission was confirmed 
by (B) Southern blot and (C) PCR 
analysis. (D–G) GRP expres-
sion in the (D and E) DRGs and 
(F and G) spinal cords of (D and F) 
wild-type mice and (E and G) 
Grp–/– mice. (H–O) Expression 
of (H–J) CGRP and (K–O) GRP 
in the lumbar spinal cords of 
C57BL/6J mice 14 days after uni-
lateral dorsal rhizotomy (L5). On 
contralateral sides, both (H and I) 
CGRP+ and (K, L, and N) GRP+ 
fibers were mainly in the super-
ficial dorsal horn (lamina I, IIo); 
but on the ipsilateral sides, both 
(H and J) CGRP and (K, M, and 
O) GRP staining was lost after uni-
lateral L5 dorsal rhizotomy. Arrows 
indicate the elimination of staining. 
n = 3 per group. (P) Quantitation 
of remaining CGRP+ (15.1%) and 
GRP+ (10.2%) staining in the L5 
superficial dorsal horn after rhizo-
tomy. Boxed areas in L and M are 
shown at higher magnification 
in N and O. Scale bar: 10 μm 
(D and E); 20 μm (F and G); 
40 μm (H–O).
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fibers seen in BRAFNav1.8 mice, indicating that the latter was due to 
developmental changes and unlikely to contribute to the chronic 
itch behavior phenotypes. Taken together, these results reveal that, 
in mouse models of ACD and dry skin itch, ectopic ERK activation 
and expression of GRP and Mrgpra3 occurred similarly to that in 
BRAFNav1.8 mice and suggest that pERK and GRP/GRPR signaling 
are critical for the progression and maintenance of long-lasting itch 
transmission (Figure 9P).
Discussion
Here, we identify the BRAF pathway as an upstream regulator of 
expression of a cohort of itch mediators in mouse sensory neu-
rons. Our data further demonstrate that GRP/GRPR signaling 
plays an important role in the initiation and maintenance of 
long-lasting itch in 3 distinct genetic and/or clinically relevant 
chronic itch models. Finally, our data suggest that a phenotypic 
switch from nociceptors to pruriceptors underlies the transition 
from acute itch signaling to pathological itch state.
BRAFNav1.8 mice are a new and unique genetic model for unravel-
ing how pruriceptive transmission is progressively enhanced at the 
molecular and circuit levels, as increasing scratching behavior cor-
relates well with an expression profile change of itch mediators. The 
fact that enhanced evoked scratching preceded the manifestation 
of spontaneous itch (from 3 weeks of age to around 6 weeks of age) 
suggests the existence of a postnatal period for developmental mat-
uration of itch circuitry as well as a threshold for the intensity of 
ongoing itch signaling. We cannot exclude the possibility that skin 
lesion or inflammation resulting from excessive scratching might 
have contributed to further increase of scratching as mice age. 
Interestingly, we have observed more pERK+ fiber innervation in 
the skin. Coupled with increased GRP+ fiber innervation in skin of 
mice with atopic dermatitis (43), it will be interesting to see whether 
the interactions between skin lesion/inflammation and enhanced 
itch-specific nerve innervation are part of positive feedback 
mechanisms that are engaged to provoke more itching signaling 
and exacerbate scratching response. In both ACD and dry skin 
models, similar progressively increased scratching responses were 
observed, albeit in a much shorter period, suggesting that skin sen-
sitization/inflammation may account for at least some aspects of 
peripheral and central sensitization of itch signaling.
Because the total number of sensory neurons remained unal-
tered, the finding that substantial de novo expression of GRP 
and Mrgpra3 primarily concentrated in TRPV1+ neurons implies 
that a small subset of nociceptors has acquired novel pruriceptive 
properties. Similar de novo neuronal responsiveness to prurito-
gens has been observed in mice with dry skin (41). Our finding 
that a population of tonic firing sensory neurons was signifi-
cantly expanded at the expense of SS cells indicates that some 
nociceptors switched from unresponsive to responsive or excitable 
to pruritogenic stimuli. We refer to cells that express in situ 
itch mediators as “primary pruriceptors,” which form the basal 
circuits for acute itch transmission, while cells expressing de novo 
itch mediators are “secondary pruriceptors.” Mechanistically, we 
suggest that a recruitment of secondary pruriceptors is a prereq-
uisite for initiating and sustaining prolonged pruriceptive trans-
mission. This phenotypic switch mechanism may also underlie 
central sensitization of itch in the context of chronic itch.
Our studies reveal that enhanced and persistent expression of 
GRP in sensory neurons is necessary for transmitting itch-specific 
information to the spinal cord in chronic itch states. A sustained 
release of GRP may necessitate additional GRPR signaling or the 
secondary itch neurons, so that the capacity of the central itch 
circuit is expanded to accommodate the amplified itch signaling 
to the brain. It remains unclear, however, which subpopulation of 
dorsal horn neurons is capable of expressing de novo GRPR. The 
present study confirms the specificity of the anti-GRP antibody 
(27, 29) as well as primary afferents as the source of GRP protein 
in the superficial dorsal horn, which was first demonstrated in rats 
(44). While it has been known that Grp mRNA is expressed in the 
dorsal horn (45, 46), importantly, chronic itch did not upregulate 
Figure 7
Genetic and pharmacologic blockade of spontaneous scratch-
ing behavior in BRAFNav1.8 mice. (A) Spontaneous scratching of 
BRAFNav1.8 mice was significantly attenuated in Grp–/– or Grpr 
KO background and in mice treated with i.t. bombesin-saporin 
(BB-sap). *P < 0.05, **P < 0.01, 1-way ANOVA followed by post-
hoc analysis, wild-type vs. BRAFNav1.8 mice. (B) GRP blocker 77427 
(i.p.) significantly reduced scratching elicited by GRP (i.t.) or CQ 
(i.d.) in wild-type mice but not in Grp–/– or Grpr KO mice. (C) Spon-
taneous scratching of BRAFNav1.8 mice was significantly reduced 
by i.p. injection of 77427 or the H1R antagonist chlorpheniramine 
(CRP) or i.t. injection of a MEK inhibitor, U0126. (D) Scratching 
behavior of mice induced by i.d. CQ and histamine did not differ 
after i.t. U0126. *P < 0.05, **P < 0.01, 2-tailed t test vs. vehicle 
controls. n = 6–10.
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ACD and dry skin models suggest that different types of persis-
tent pruriceptive stimuli may differentially trigger pERK signal-
ing in different subsets of pruriceptors. For example, although 
ERK was activated, no upregulation of H1R was observed in ACD 
or dry skin models. Moreover, despite ERK activation and ectopic 
expression of GRP in DRG neurons and GRPR in the spinal 
cord, the temporal and spatial patterns of spontaneous scratch-
ing between these chronic itch models differ dramatically. Thus, 
behavioral output encoded by the sustained ERK activation in 
sensory neurons may be dictated by the nature of a pruriceptive 
stimulus as well as the state of itch or pain sensitization. A com-
binatorial activation of itch mediators and types of neurons in 
which they are activated is manifest in the duration, intensity, 
and regional patterns of itch response, the last of which is also 
inherently restrained by the areas in which a mouse can reach and 
scratch using its hind limbs.
How is ERK signaling triggered upon acute contact dermatitis 
or dry skin induction? A host of extracellular stimuli can 
activate ERK signaling (21, 22, 51), making it possible that height-
ened levels of such factors in the extracellular milieu as a result 
of local metabolic dysregulation or inflammation can stimulate 
intracellular BRAF to augment itch signaling. Considering the 
progressive development of chronic itch, it is possible that these 
factors may also activate a diverse group of GPCRs, which in 
turn initiates the RAF/MEK/ERK cascade (21, 52). As a result, an 
amplified BRAF signal may further sensitize itch circuits through 
a positive feedback loop via GPCR-dependent integration of 
downstream ERK signaling. Identification of ERK-dependent 
transcriptional events would be a logical next step to link 
extracellular stimuli to the expression of downstream effector genes 
that encode itch information. Finally, the present study supports 
the role of GRP as an itch-specific neuropeptide in sensory neurons, 
in agreement with previous findings that GRP was upregulated in pri-
mary afferents of primates with chronic itch (53) and in patients (54). 
GRP protein in spinal interneurons. The corroborative evidence, 
therefore, led us to conclude that spinal Grp mRNA does not 
equate to GRP protein expression. Failure to detect Grp mRNA 
in DRG neurons by ISH or lack of EGFP in DRGs of GRP-EGFP 
transgenic mice highlights the technical limitations that have 
resulted in differing interpretation (29, 47).
Complementary to our loss-of-function studies (12, 13), the find-
ing that a dramatic upregulation of GRP/GRPR signaling failed to 
impact both acute and chronic pain behavior of BRAFNav1.8 mice 
in a profound manner reinforces the idea that GRP/GRPR sig-
naling represents a dedicated molecular labeled line for itch from 
periphery to the spinal cord. This is in contrast to B-type natriuretic 
peptide (BNP), which has recently been proposed to be dedicated 
to activation of its receptor natriuretic peptide receptor-A (NPRA) 
for itch transmission from DRGs to the spinal cord (47). However, 
BNP-NPRA–mediated autoregulation in DRG neurons was also 
implicated in nociceptive processing in DRG neurons (48). Indeed, 
we found that i.t. injection of BNP also regulated inflammatory 
pain behavior (Zhao et al., unpublished observations).
BRAFNav1.8 mice enable us to position BRAF signaling upstream 
of key itch effectors in sensory neurons of mice with chronic itch. 
Notably, unlike DRG neurons, pERK activation in the spinal cords 
of mice with ACD and dry skin occurred only transiently after 
skin was acutely sensitized and was absent the following day when 
spontaneous scratching was persistent. This suggests that pERK 
activation in the spinal cord is dispensable for maintaining cen-
tral sensitization of itch. Nonetheless, the capability of the BRAF 
signaling cascade to regulate expression of a wide range of itch 
mediators from histaminergic itch to nonhistaminergic itch genes 
reveals a remarkable molecular and cellular specificity as well as 
plasticity intrinsic to sensory neurons.
ERK signaling was differentially activated in nociceptors in 
response to varying noxious stimuli (49, 50). While it is unclear 
why pruriceptive genes are selectively activated, our analyses of 
Figure 8
Analysis of skin and immune system in adult mice with ACD. 
(A) H&E and toluidine blue staining of the neck skin of the 
mice with ACD and the control mice. The mice with ACD 
showed epidermal hyperplasia, hyperkeratosis, acanthosis, 
dermal inflammation, and mast cell infiltration (insets show 
a few mast cells). Scale bar: 25 μm. (B and C) The systemic 
manifestations of allergic dermatitis were presented as high-
lighted by their (B) enlarged spleen and lymph nodes and 
(C) significantly increased blood neutrophil counts. SPL, 
spleen. Scale bar: 4 mm. (D) Quantitative analysis con-
firmed that ACD enhanced the extent of mast cell infiltration 
in the dermis. Mast cells in 9 random ×200 microscope fields 
were counted and averaged. (E) IgE levels were highly ele-
vated in mice with ACD. (F) Tslp mRNA was overexpressed 
in the ACD skin. Representative RT-PCR images (bottom). 
*P < 0.05, **P < 0.01, ***P < 0.001, mice with ACD vs. the 
controls (acetone only). n = 6.
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harboring the genotypes Nav1.8WT/WT with BrafV600E, Nav1.8Cre/WT with 
BrafWT/WT, and Nav1.8WT/WT with BrafWT/WT were used as controls. Generation 
of Grpr KO mice and GRPR-EGFP mice was described previously (12, 56, 57). 
For generation of Grp–/– mice, see the Supplemental Methods.
Behavioral studies. The motor, itch, and pain behavioral studies were 
performed as described previously (12, 13). Chronic itch models were 
used as described previously (40, 58).
Immunohistochemistry and ISH. Standard procedures were used as 
described previously (59).
RT-PCR and Western blot analysis. RT-PCR and Western blot analysis were 
carried out as described previously (11).
Calcium imaging and electrophysiology. Dissociated DRG neurons were loaded 
with fura 2-acetoxymethyl ester (Invitrogen) and imaged at 340 and 380 nm 
We suggest that an upregulation of GRP/GRPR represents a hall-
mark of the development of chronic itch. A repertoire of pharma-
cologic inhibitors of the BRAF cascade in clinical trials for patients 
with cancer (55) may be used in combination with inhibitors of 
GRP or GRPR to provide a more effective strategy for ameliorating 
chronic itch conditions than either type of inhibitor alone.
Methods
Additional details regarding this study are provided in the Supplemental 
Methods.
Mice. Mice with a floxed allele for BrafV600E (V600Ef/WT mice) (24) were 
crossed with Nav1.8Cre/+ mice (25) to generate mice with specific expression of 
BrafV600E in Nav1.8+ cells (referred to herein as BRAFNav1.8 mice). Littermates 
Figure 9
Mice with ACD- and dry skin–induced itch recapitulate the phenotype of BRAFNav1.8 mice. (A) Mice with ACD induced by DNFB exhibited progres-
sively increased scratching behavior. Red arrows indicate the time points when DNFB was applied, and spontaneous scratches were counted 
24 hours afterward. n = 7. (B) Progressively increased scratching behavior was induced in mice with dry skin itch. n = 13. (C) Spontaneous scratching 
of mice with ACD or dry skin was significantly reduced by i.t. U0126. n = 5~9 per group. *P < 0.05, **P < 0.01, mice treated with U0126 vs. the con-
trols. (D–F) Ectopic activation of ERK and (G–I) expression of GRP. (J–L) Mrgpra3 in DRGs and (M–O) GRPR as shown by GFP staining (E, H, 
K, and N) in the dorsal horns of mice with ACD compared to (D, G, J, and M) the controls (acetone only). In M–O, GRPR-EGFP mice were used. 
Results in F, I, L, and O are quantitative comparisons between 2 groups (n = 3 per group). Scale bar: 10 μm (D, E, G, and H); 20 μm (J, K, M, and N). 
(P) Diagram illustrates BRAF/MEK/ERK regulation of itch molecular phenotype in DRG. *P < 0.05, ***P < 0.001, mice with ACD vs. the controls.
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excitation to detect intracellular-free calcium for analysis of the relative pro-
portions of DRG neurons responsive to pruritogens. Current clamp record-
ings were acquired on dissociated DRG neurons as described previously (60).
Skin and immune system in mice with ACD. Back neck skin and blood samples 
were harvested from mice for various analyses as described previously (61).
Statistics. Behavioral tests, cell counting, or molecular analysis were per-
formed by observers blinded to the treatments and/or genotypes of the 
animals used. Unless indicated otherwise, cervical DRGs and dorsal horns 
were used. All quantification data are presented as mean ± SEM, and error 
bars represent SEM. Statistical comparisons were performed with 1-way or 
2-way ANOVA followed by post-hoc analysis, Student’s t test, or the χ2 test, 
as specifically indicated in the figure legends. However, unless otherwise 
indicated, the statistical analyses were done using t test, and P < 0.05 was 
considered statistically significant.
Study approval. All experiments were performed in accordance with the 
guidelines of the NIH and the International Association for the Study of 
Pain and were approved by the Animal Studies Committee at Washington 
University School of Medicine and the Institutional Animal Care and Use 
Committees at Weill Cornell Medical College.
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